Literature DB >> 1520759

Two cases of endocarditis due to Lactobacillus species: antimicrobial susceptibility, review, and discussion of therapy.

J K Griffiths1, J S Daly, R A Dodge.   

Abstract

Endocarditis caused by lactobacilli may lead to death or to relapse of infection, despite antimicrobial treatment. We report two cases of lactobacillus endocarditis in individuals with native bicuspid aortic valves who survived without relapse and review the 39 other cases reported in the literature. In only 15 previously reported cases have patients been cured with medical therapy alone. One of our patients, who was infected with Lactobacillus acidophilus, was cured by medical therapy alone, and our other patient, who was infected with Lactobacillus casei subspecies rhamnosus, required surgical replacement of his aortic valve. L. acidophilus was tolerant and L. casei subspecies rhamnosus was resistant to many antibiotics tested. Combinations of penicillin or daptomycin and gentamicin were synergistic by time-kill assay. Synergistic therapy with a penicillin and an aminoglycoside was effective clinically and appears to provide optimal medical treatment on the basis of microbiological data.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1520759     DOI: 10.1093/clinids/15.2.250

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  23 in total

1.  Lactobacillemia: an emerging cause of infection in both the immunocompromised and the immunocompetent host.

Authors:  S J Antony
Journal:  J Natl Med Assoc       Date:  2000-02       Impact factor: 1.798

2.  Fatal case of endocarditis due to Weissella confusa.

Authors:  James D Flaherty; Paul N Levett; Floyd E Dewhirst; Theodore E Troe; John R Warren; Stuart Johnson
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

3.  Comparison of API 50 CH strips to whole-chromosomal DNA probes for identification of Lactobacillus species.

Authors:  Melinda A Boyd; May A D Antonio; Sharon L Hillier
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

Review 4.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

5.  Endocarditis caused by Lactobacillus.

Authors:  A Vaghjimal; L I Lutwick; E K Chapnick
Journal:  Postgrad Med J       Date:  1997-01       Impact factor: 2.401

Review 6.  Lactobacillus casei infection in an AIDS patient.

Authors:  S Abgrall; V Joly; P Derkinderen; D Decré; C Carbon; P Yeni
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-02       Impact factor: 3.267

Review 7.  Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases.

Authors:  J P Cannon; T A Lee; J T Bolanos; L H Danziger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-01       Impact factor: 3.267

8.  In vitro activities of ketolide HMR3647, macrolides, and other antibiotics against Lactobacillus, Leuconostoc, and Pediococcus isolates.

Authors:  M Zarazaga; Y Sáenz; A Portillo; C Tenorio; F Ruiz-Larrea; R Del Campo; F Baquero; C Torres
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

9.  Lactobacillus species identification, H2O2 production, and antibiotic resistance and correlation with human clinical status.

Authors:  A Felten; C Barreau; C Bizet; P H Lagrange; A Philippon
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

10.  Septicemia from Lactobacillus rhamnosus GG, from a Probiotic Enriched Yogurt, in a Patient with Autologous Stem Cell Transplantation.

Authors:  Satoshi Koyama; Hiroyuki Fujita; Takeshi Shimosato; Aki Kamijo; Yasufumi Ishiyama; Eri Yamamoto; Yoshimi Ishii; Yukako Hattori; Maki Hagihara; Etsuko Yamazaki; Naoto Tomita; Hideaki Nakajima
Journal:  Probiotics Antimicrob Proteins       Date:  2019-03       Impact factor: 4.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.